Intellus Institute 2025, 10-12 September

Team members from Blue Matter’s Insights team will be attending the Intellus Institute from 10-12 September in New Brunswick, NJ.

Blue Matter Insights leaders, D’Arcy King, Ph.D. and Andrew Pilecki, Ph.D., will deliver a presentation:

Identifying Critical Paths to Brand Adoption Using a Behavioral-Science Based Approach

Date & Time: Wednesday, Sep 10, 2025 at 1:55-2:10 PM
Location: Regency D-F, Hyatt Regency in New Brunswick, NJ

Description:

What really drives a doctor’s prescribing choice? The COM-B model proposes that it comes down to the interaction of three factors: Capability, Opportunity, and Motivation. Blue Matter Insights (BMI) developed and validated a new tool based on this model to decode prescriber behavior. In our pilot study, we analyzed 15 brands across four key therapeutic areas—metastatic breast cancer, obesity, myasthenia gravis, and atopic dermatitis—to identify distinct pathways to brand use. The result was a way to pinpoint the optimal leverage points to enact real behavioral change among customers.